First-line chemotherapy for ovarian cancer - the controversy continues

被引：2
|
作者：
Kaye, SB [1 ]
机构：
[1] Royal Marsden Hosp, Inst Canc Res, Sutton, Surrey, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 87卷 / 08期
关键词：
D O I：
10.1038/sj.bjc.6600568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 814
页数：2
相关论文
共 50 条
  • [31] Irinotecan (CPT-11) and cisplatin as first-line chemotherapy in advanced ovarian cancer.
    Sugiyama, T
    Noda, K
    Yakushiji, M
    Kamura, T
    ANNALS OF ONCOLOGY, 2000, 11 : 86 - 86
  • [32] Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat, Patrick
    du Bois, Andreas
    Bruchim, Ilan
    Fink, Daniel
    Provencher, Diane M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (02) : 137 - 147
  • [33] The impact of age on first-line chemotherapy treatment of epithelial ovarian cancer and primary peritoneal carcinoma
    Larbi, E.
    Madhuri, T. K.
    Essapen, S.
    Michael, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] The effect of protocol inclusion on the outcomes of ovarian cancer patients receiving first-line chemotherapy.
    Brown, AK
    Donfrancesco, S
    Granai, CO
    Disilvestro, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 471S - 471S
  • [35] Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
    Papadimitriou, CA
    Kouroussis, C
    Moulopoulos, LA
    Vlahos, G
    Rodolakis, A
    Kiamouris, C
    Diakomanolis, E
    Gika, D
    Michalas, S
    Dimopoulos, MA
    CANCER, 2001, 92 (07) : 1856 - 1863
  • [36] Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
    Li, Xin-Ru
    Cheng, Xing-Han
    Zhang, Guo-Nan
    Wang, Xiao-Xin
    Huang, Jian-Ming
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [37] Bevacizumab with dose-dense paclitaxel/carboplatin as first-line chemotherapy for advanced ovarian cancer
    Zhang, Li
    Zhou, Qi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 837 : 64 - 71
  • [38] First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients
    Romanini, A
    Tanganelli, L
    Carnino, F
    Fanucchi, A
    Lionetto, R
    Pastorino, S
    Cosio, S
    Gadducci, A
    Conte, PF
    GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 354 - 359
  • [39] Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
    Tuxen, MK
    Sölétormos, G
    Dombernowsky, P
    BRITISH JOURNAL OF CANCER, 2001, 84 (10) : 1301 - 1307
  • [40] Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients
    Beesley, Vanessa L.
    Clavarino, Alexandra M.
    Webb, Penelope M.
    Wyld, David K.
    Francesconi, Alessandra B.
    Horwood, Keith R.
    Doecke, James D.
    Loos, Colleen A.
    Green, Adele C.
    SUPPORTIVE CARE IN CANCER, 2010, 18 (08) : 943 - 949
12345